Skin acts as the first line of defense against pathogens and other harmful material from outside the body. Yet this barrier also excludes some beneficial drugs that could treat skin diseases. Now, researchers have taken the first steps in developing a chemotherapy for melanoma that can be “painted” directly on the skin, rather than injected or taken orally.
They report their results in ACS Nano.
According to the Skin Cancer Foundation, melanoma is the deadliest form of cancer because of its tendency to spread, or metastasize, from the skin to other parts of the body. Common treatments include surgery, radiation therapy and intravenous chemotherapy, but these can cause pain or unpleasant side effects. If scientists could find a way to administer chemotherapy through the skin, they could target the treatment directly to the tumor site and possibly avoid side effects. Bingfang He, Ran Mo and colleagues wanted to develop a gel that patients themselves could apply to a skin tumor. But first they had to figure out how to get the therapy to penetrate deep within the skin.
For this purpose, the researchers assembled nanoparticles called “transfersomes,” which consist of a phospholipid bilayer and surfactants that encapsulate drugs or other molecules — in this case, the chemotherapy drug paclitaxel. The surfactants made the particles more deformable so that they could better infiltrate the skin; these compounds also affected the lipid matrix of the skin to help the particles more easily pass. The researchers added a peptide to the surface of the transfersome to further help the particle penetrate the skin, as well as enter tumor cells. To increase the time that the transfersomes persisted on skin, the researchers embedded the nanoparticles into a hydrogel. Then, they painted the gel on tumors of melanoma-bearing mice once a day, in combination with intravenous administration of paclitaxel every other day. After 12 days, the tumors of these mice were about half the size of tumors in mice treated with intravenous paclitaxel alone, suggesting that the transfersome gel helped slow tumor growth.
Learn more: Paintable chemotherapy shrinks skin tumors in mice
The Latest on: Melanoma
[google_news title=”” keyword=”melanoma” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Melanoma
- Gene signatures from tissue-resident T cells as a predictive tool for melanoma patientson May 2, 2024 at 10:51 am
A new study has revealed an association between favorable survival outcomes for melanoma patients and the presence of higher populations of tissue-resident memory T cells (TRM). Data obtained from ...
- Myth that tan skin looks healthier persists for a third of young adultson May 2, 2024 at 10:41 am
Nearly a third of Americans (32%) think that a tan makes people look better and healthier, a dangerous beauty standard that can increase a person's risk of skin cancer, poll results show.
- Personalised mRNA vaccines: a revolutionary new approach in melanoma treatmenton May 2, 2024 at 8:46 am
Personalised mRNA vaccines represent a paradigm shift in cancer therapy – offering a highly targeted and adaptable approach to treatment. By harnessing the body’s immune system to selectively target ...
- What is acral melanoma? Symptoms of skin cancer on black and brown skin to look out foron May 2, 2024 at 7:31 am
Acral melanoma is the most common form of skin cancer in black and brown skin, but it's often left out of the conversation.
- Dermatology Duluth is ready to help you on Melanoma Mondayon May 2, 2024 at 5:41 am
May is Skin Cancer Awareness Month. And Melanoma Monday is coming up on May 6th. It’s a chance for you to get your skin checked for free at certain dermatology offices. Dermatology Duluth is offering ...
- Alarming time-lapse video reveals how tiny ‘dark patch’ morphs into melanomaon May 2, 2024 at 3:27 am
AN alarming time-lapse video shows how a tiny dark patch of skin can morph into killer melanoma cancer over a decade. Doctors urge us all to be on the be on the lookout for new moles or changes to ...
- Adding cellular therapy to the arsenal against metastatic melanomaon May 1, 2024 at 5:00 pm
Patients in South Florida with metastatic melanoma will soon have access to the first cellular therapy for this advanced form of skin cancer, following its recent approval by the Food and Drug ...
- Acral melanoma: Doctor explains symptoms of little-known cancer that is now in the spotlighton May 1, 2024 at 7:16 am
Every May, more light is shone on skin cancer in a bid to raise awareness of the disease - and also educate members of the public who may be going about their day-to-day lives undiagnosed ...
- Melanoma Research Alliance Announces $12.6 Million Investment in Cutting Edge Melanoma Researchon May 1, 2024 at 6:01 am
The Melanoma Research Alliance (MRA), the world's leading non-profit funder of melanoma research, announced its $12.6 million commitment to fund melanoma research supporting more than 30 scientists at ...
via Bing News